ArticleTransplantation direct2026

Immune Checkpoint Inhibitor Therapy of Malignancy in Kidney Transplant Recipients: Analysis of Real-world Outcomes.

Ali Rezazadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.